Levomecol 

Levomecol (Chloramphenicol), made up of Chloramphenicol, Methyluracil, is a broad-spectrum antibiotic that is derived from the bacterium Streptomyces venezuelae. Levomecol (Chloramphenicol)) stops bacterial growth by binding to the bacterial ribosome (blocking peptidyl transferase) and inhibiting protein synthesis^[1][2][3].

Peptidyl transferase^[1]

Levomecol (solution applied on the wound for 14 consecutive days) can inhibit the infiltration of mast cells and stimulate the infiltration of lymphocytes and macrophages (monocytes) into the wound, and has antibacterial activity on rats infected with pathogens^[2].
Levomecol (40% ointment solution) can effectively correct the disorder of tissue apoptosis in the occurrence of ischemic complications in rats with diabetes^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

449.24

C₁₆H₁₈Cl₂N₄O₇

118573-58-3

O=C(N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1)C(Cl)Cl.O=C2NC(C(C)=CN2)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Chloramphenicol

  [2]. Babenkov HD, et al. [The influence of photochemically activated 40% solution of levomecol ointment toward apoptosis in muscles of the rats posterior extremities in inflammatory-purulent complications of diabetes mellitus]. Klin Khir. 2006 Jul;(7):58-60. Ukrainian  [Content Brief]

  [3]. Babenkov HD, et al. [The influence of photochemically activated 40% solution of levomecol ointment toward apoptosis in muscles of the rats posterior extremities in inflammatory-purulent complications of diabetes mellitus]. Klin Khir. 2006 Jul;(7):58-60. Ukrainian.  [Content Brief]